Current Status of the Third-Line Helicobacter pylori Eradication.

about

Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency

P2860

Q59130100-369F97BA-2937-41E2-AD6D-9C37DC68D3AB

P2860

Current Status of the Third-Line Helicobacter pylori Eradication.

Item

http://www.wikidata.org/entity/Q55056772

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Current Status of the Third-Line Helicobacter pylori Eradication.

@en

Current Status of the Third-Line Helicobacter pylori Eradication.

@nl

type

Item

label

Current Status of the Third-Line Helicobacter pylori Eradication.

@en

Current Status of the Third-Line Helicobacter pylori Eradication.

@nl

prefLabel

Current Status of the Third-Line Helicobacter pylori Eradication.

@en

Current Status of the Third-Line Helicobacter pylori Eradication.

@nl

P1476

Current Status of the Third-Line Helicobacter pylori Eradication.

@en

P2093

Gwang Ho Baik

http://www.w3.org/2001/XMLSchema#string

Jae Ho Choi

http://www.w3.org/2001/XMLSchema#string

Jae Jun Lee

http://www.w3.org/2001/XMLSchema#string

P2860

New concepts of resistance in the treatment of Helicobacter pylori infections

Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection

Kyoto global consensus report on Helicobacter pylori gastritis

Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection

Helicobacter pylori infection and the development of gastric cancer

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.

Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura.

Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials.

Antibiotic-resistant H. pylori infection and its treatment.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

P304

6523653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/6523653

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Chang Seok Bang

Young Joo Yang

P577

2018-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29853863

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

5954858

http://www.w3.org/2001/XMLSchema#string

Current Status of the Third-Line Helicobacter pylori Eradication.

about

P2860

P2860

Current Status of the Third-Line Helicobacter pylori Eradication.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932